NCT05982574View on ClinicalTrials.gov

Tumor Microenvironment

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2026

Study Completion Date

December 31, 2026

Conditions

Lung Adenocarcinoma

All Listed Sponsors

lead

University Hospital Heidelberg

OTHER

NCT05982574 - Tumor Microenvironment | Biotech Hunter | Biotech Hunter